Published • loading... • Updated
AMGEN REPORTS SECOND QUARTER 2026 FINANCIAL RESULTS
Revenue climbed to $10.1 billion as demand for Repatha and Evenity offset weaker Prolia sales, while Amgen lifted its full-year outlook.
Summary by PR Newswire
8 Articles
8 Articles
·London, United Kingdom
Read Full Article
Adams Street tops $5bn for secondaries programme as record deal volumes fuel latest raise
Adams Street Partners has raised more than $5bn for its latest secondaries investment programme, as the private markets investor looks to capitalize on a secondary market that surpassed $200bn of annual transaction volume for the first time last year. The post Adams Street tops $5bn for secondaries programme as record deal volumes fuel latest raise appeared first on AltAssets Private Equity News.
Coverage Details
Total News Sources8
Leaning Left0Leaning Right0Center6Last UpdatedBias Distribution100% Center
Bias Distribution
- 100% of the sources are Center
100% Center
C 100%
Factuality
To view factuality data please Upgrade to Premium
